ABSTRACT
INTRODUCTION: Central nervous system (CNS) metastasis from nasopharyngeal carcinoma (NPC) is rare and presents with high morbidity and mortality. As a rare entity, a few patients with CNS metastasis from NPC have been reported, and no studies were available on treatment and prognosis. Based on our clinical experience, early diagnosis with incorporation of a clear palliative plan is imperative in providing holistic care for patients with locally-invasive and metastatic nasopharyngeal carcinoma. CASE REPORT: Our study reports a case of a 48-year-old Filipino male with known NPC Stage IVB who developed acute symptoms of constipation, urinary retention, and bilateral lower limb weakness and numbness. Magnetic resonance imaging showed intramedullary lesions in multiple segments of the spinal cord. Steroid and radiotherapy of the spine were initiated with noted transient improvement of the motor strength. Subsequently, he developed cancer-related stroke. The patient progressively deteriorated despite best medical care.
Subject(s)
Carcinoma, Squamous Cell/pathology , Nasopharyngeal Carcinoma/pathology , Nasopharyngeal Neoplasms/pathology , Spinal Cord Neoplasms/secondary , Humans , Male , Middle Aged , Philippines , Spinal Cord Neoplasms/therapy , Treatment OutcomeABSTRACT
Ease of access to vast amounts of information presents significant opportunities and challenges for nurses in the community as they seek to base their practice on the best available evidence. Growing expectations around evidence-based practice have developed alongside developments in evidence synthesis, which adopts robust approaches to identifying, appraising and synthesising key evidence for clinical decision-making. The context in which evidence-based practice occurs is key, and this article discusses the skills and knowledge needed for community nurses to discern how evidence and information should influence their decisions to review and change approaches to clinical practice. Importantly, if nurses understand the status of evidence underpinning areas of practice, they can ensure that the preferences and needs of patients and families are met.
Subject(s)
Community Health Nursing/methods , Evidence-Based Nursing , Review Literature as Topic , Systematic Reviews as Topic , Clinical Decision-Making , Clinical Nursing Research/methods , Community Health Nursing/standards , Health Knowledge, Attitudes, Practice , Humans , Spinal Cord Compression/etiology , Spinal Cord Compression/nursing , Spinal Cord Neoplasms/complications , Spinal Cord Neoplasms/secondaryABSTRACT
BACKGROUND: Distant metastases from differentiated thyroid carcinoma occur in up to 20% of cases and represent the most frequent cause of thyroid cancer-related death. Metastatic disease to the spine has the potential to cause severe morbidity, including pain, neurological deficit, and paraplegia. SUMMARY: We present a case series of eight consecutive patients with symptomatic spinal metastases due to thyroid carcinoma treated by our multidisciplinary team consisting of spinal surgeons, oncologists, and radiologists, with management of each case determined by our surgical algorithm. Four patients underwent surgical decompression and stabilization for spinal metastases causing instability, spinal cord compression, neurological deficit, or intractable pain. Three patients underwent vertebroplasty for focal mechanical pain due to osteolytic metastases in the absence of significant spinal cord compression or spinal instability; one of these patients required subsequent surgical decompression for spinal cord compression. One patient was nonoperatively treated. All patients underwent total thyroidectomy for the primary cancer and adjuvant radioiodine-131 treatment. The only patient with poorly differentiated thyroid cancer, which was refractory to radioiodine-131 died at 6 months after vertebroplasty procedures for symptomatic spinal metastases. One patient with medullary thyroid carcinoma died at 18 months after vertebroplasty. All remaining six patients who had well-differentiated papillary or follicular thyroid carcinoma were alive at an average of 50 months (range: 17-96 months) after diagnosis and treatment of symptomatic spinal metastases and were ambulant, independent, and able to perform activities of daily living and had no significant pain or neurologic symptoms. CONCLUSION: The potential for long-term survival of several years following development of spinal metastases should be considered during the counseling and decision-making process for patients with thyroid cancer.
Subject(s)
Carcinoma/mortality , Carcinoma/therapy , Spinal Cord Neoplasms/mortality , Spinal Cord Neoplasms/secondary , Thyroid Neoplasms/mortality , Thyroid Neoplasms/therapy , Activities of Daily Living , Aged , Carcinoma/secondary , Combined Modality Therapy , Female , Humans , Iodine Radioisotopes/therapeutic use , Male , Middle Aged , Spinal Cord Compression/surgery , Thyroid Neoplasms/pathology , Thyroidectomy , VertebroplastyABSTRACT
OBJECTIVE AND IMPORTANCE: Intramedullary spinal cord metastasis (ISCM) comprises 8.5% of central nervous system metastases and confers significant morbidity. Radioresistant histologies such renal cell carcinoma and melanoma are not generally amenable to long-term palliation with conventional radiotherapy while surgery has often been found to be technically challenging and frequently morbid. In this report, we present a patient with a C5 ISCM from renal cell carcinoma treated with fractionated stereotactic radiosurgery. CLINICAL PRESENTATION: A 50-year-old gentleman with metastatic renal cell carcinoma presented with profound bilateral shoulder pain and upper extremity paresthesias. Magnetic resonance imaging revealed an intramedullary lesion at the level of fifth cervical vertebra (C5). Medical management and chiropractic manipulation proved to be ineffective. The patient was then treated with external beam radiation therapy, but continued to experience severe pain, paresthesias, and progressive, profound neurologic symptoms. INTERVENTION: The patient was referred to radiation oncology and neurosurgery for evaluation. Consideration was given to cordotomy and resection but the location and procedure was deemed to be high-risk and therefore was deferred. The decision was made to treat with fractionated stereotactic radiosurgery. A dose of 15Gy was successfully delivered in 3 fractions to the 80% isodose line without complication or adverse effects. Twenty-six months following treatment, the patient was still alive, fully functional, and reported no pain and rare of paresthesias. CONCLUSION: Fractionated stereotactic radiosurgery is a feasible, safe, and effective modality for the treatment of ICSM and should be carefully considered in the management of this difficult to treat condition.
Subject(s)
Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Radiosurgery , Spinal Cord Neoplasms/secondary , Spinal Cord Neoplasms/surgery , Surgery, Computer-Assisted , Headache/etiology , Humans , Hypertension/complications , Magnetic Resonance Imaging , Male , Middle Aged , Paresthesia/etiology , Seizures/etiologySubject(s)
Astrocytoma/pathology , Brain Neoplasms/pathology , Optic Nerve Neoplasms/secondary , Spinal Cord Neoplasms/secondary , Thalamus/pathology , Vision, Low/etiology , Adolescent , Antineoplastic Agents, Alkylating/pharmacology , Antineoplastic Agents, Alkylating/therapeutic use , Astrocytoma/radiotherapy , Biomarkers, Tumor , Brain Neoplasms/radiotherapy , Dacarbazine/analogs & derivatives , Dacarbazine/pharmacology , Dacarbazine/therapeutic use , ErbB Receptors/genetics , Humans , Intracranial Hypertension/etiology , Intracranial Hypertension/physiopathology , Magnetic Resonance Imaging , Male , Neoplasm Metastasis/pathology , Neoplasm Metastasis/physiopathology , Optic Nerve/pathology , Optic Nerve/physiopathology , Optic Nerve Neoplasms/radiotherapy , PTEN Phosphohydrolase/genetics , Papilledema/etiology , Papilledema/physiopathology , Phosphatidylinositol 3-Kinases/genetics , Spinal Cord Neoplasms/radiotherapy , Subarachnoid Space/pathology , Subarachnoid Space/physiopathology , Temozolomide , Vision, Low/cerebrospinal fluidABSTRACT
Nearly 6,750,000 people suffer moderate to severe cancer-related pain each year. Unfortunately, 10% to 15% of these patients fail to achieve acceptable pain relief with conventional management. Spinal cord stimulation (SCS) has been used with increased frequency for successful treatment of intractable cancer pain. We present two cases of intractable, refractory-to-conventional treatment cancer pain that were successfully treated with SCS. Case 1 reports a 51-year-old male with burning pain at the left groin site of inguinal metastases, post-surgical and intraoperative radiation therapy for treatment of squamous cell carcinoma of the anus. Case 2 reports a 43-year-old woman with intractable, burning, throbbing, and shooting pain, post-debulking followed by radiation of a metastatic colon carcinoma. In both cases SCS implantation provided 90% to 100% pain relief, improved functioning and sleep, and discontinuation of pain medications, sustained through 12 months.
Subject(s)
Anus Neoplasms/therapy , Carcinoma, Squamous Cell/therapy , Colonic Neoplasms/therapy , Electric Stimulation Therapy , Neuralgia/therapy , Spinal Cord Neoplasms/therapy , Spinal Cord , Adult , Female , Humans , Male , Middle Aged , Neoplasm Metastasis , Palliative Care , Spinal Cord Neoplasms/secondaryABSTRACT
The association of weight loss and pediatric brain tumors that affect the diencephalon or brain stem with weight loss is a recognized, but not fully understood phenomenon. Tumors located in the hypothalamic region may induce the diencephalic syndrome (DS), which is characterized by profound emaciation with almost complete loss of subcutaneous fatty tissue. Tumors that compress or infiltrate the brain stem rarely cause both psychological disturbance and emaciation. The clinical presentation may be different, depending on the location of the lesion and age of the patient. In this report we present an unusual case of severe emaciation in a 4(9)/(12)-year-old girl with a juvenile pilocytic astrocytoma of the hypothalamic region and brain stem with neuroaxis dissemination. This case illustrates the importance of considering intracranial mass-lesions in the differential diagnosis of weight loss, psychological disturbance and atypical eating disorder. We discuss the importance of tumor multifocality and the role of patient age in the clinical presentation with reference to the literature.
Subject(s)
Astrocytoma/pathology , Brain Neoplasms/pathology , Emaciation/etiology , Feeding and Eating Disorders/etiology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Astrocytoma/complications , Astrocytoma/drug therapy , Brain Neoplasms/complications , Brain Neoplasms/drug therapy , Brain Stem/pathology , Child, Preschool , Diagnosis, Differential , Emaciation/pathology , Emaciation/surgery , Feeding and Eating Disorders/pathology , Feeding and Eating Disorders/surgery , Feeding and Eating Disorders of Childhood/diagnosis , Female , Humans , Hypothalamus/pathology , Spinal Cord Neoplasms/complications , Spinal Cord Neoplasms/secondary , Treatment OutcomeABSTRACT
Malignant peripheral nerve sheath tumors are rare spindle-cell sarcomas derived from Schwann cells or pluripotent cells of the neural crest. They arise from the spinal roots, peripheral nerves, brachial and lumbosacral plexi, cranial nerves and terminal nerve fibers within soft tissue, intestine, lung and bone. These tumors recur either locally, or metastasize distally. Most of these tumors occur in association with neurofibromatosis type 1. Spinal cord metastasis from malignant nerve sheath tumors associated with neurofibromatosis type 1 is very rare. We describe a rare case of near-total spinal cord metastasis in a patient with malignant nerve sheath tumor in the absence of neurofibromatosis, and highlight the microscopic findings and natural history of this disease process.
Subject(s)
Lung Neoplasms/secondary , Nerve Sheath Neoplasms/pathology , Neurofibroma/pathology , Spinal Cord Neoplasms/secondary , Adult , Benzenesulfonates/therapeutic use , Chemotherapy, Adjuvant , Fatal Outcome , Female , Humans , Lung Neoplasms/therapy , Magnetic Resonance Imaging , Nerve Sheath Neoplasms/surgery , Neurofibroma/therapy , Niacinamide/analogs & derivatives , Phenylurea Compounds , Pyridines/therapeutic use , Sorafenib , Spinal Cord Neoplasms/therapyABSTRACT
OBJECTIVE: To highlight the utility of Cyriax's selective tissue-tensioning principles, specifically the "Sign of the Buttock," in identifying mechanical behavior of pain of pathologies not amenable to conservative treatment. CLINICAL FEATURES: A 41-year-old man was referred to the University of Pittsburgh Medical Center Spine Specialty Center with a diagnosis of L5-S1 herniated nucleus pulposis that was recalcitrant to treatment. The onset of symptoms had been 5 months before the patient's appointment at the Spine Center and 6 months after an apparent precipitating trauma. The patient had been followed up by his primary care physician, referred to urology, neurosurgery, and physical medicine and rehabilitation before being referred to the Spine Specialty Center. INTERVENTION AND OUTCOME: Clinical examination using Cyriax's Sign of the Buttock implicates the hip joint, while it helps to rule out the lumbar spine. Review of previous imaging studies failed to rule out hip pathology. Pelvis and hip magnetic resonance imaging led to suspicion of lytic lesions, and a diagnosis of metastatic adenocarcinoma was made via biopsy. CONCLUSION: We have found Cyriax's Sign of the Buttock to have diagnostic value in this case. When positive, this test may help identify serious extracapsular hip or pelvic pathology.
Subject(s)
Adenocarcinoma/diagnosis , Adenocarcinoma/secondary , Intervertebral Disc Displacement/diagnosis , Lumbar Vertebrae , Lung Neoplasms/pathology , Physical Examination , Spinal Cord Neoplasms/diagnosis , Spinal Cord Neoplasms/secondary , Adult , Diagnosis, Differential , Humans , MaleABSTRACT
Medulloblastoma (MB), the most common pediatric brain tumor, is a highly malignant disease with a 5-year survival rate of only 60%. Tumor cells invade surrounding tissue and disseminate through cerebral spinal fluid, making treatment difficult. Human reovirus type 3 exploits an activated Ras pathway in tumor cells to support productive infection as an oncolytic virus. Here, we examined the ability of human reovirus to kill MB cells lines and surgical specimens in vitro and inhibit tumor growth/metastases in vivo. Most human MB cell lines tested (five of seven = 71.4%), two MB cell lines derived from spontaneously arising tumors in Patched-1(+/-) mice (two of two = 100%) and three MB primary cultures derived from surgical specimens, were susceptible to reovirus infection. Reovirus was internalized and transcribed in both susceptible and resistant cell lines. However, viral protein synthesis was restricted to cell lines with higher levels of activated Ras, suggesting that Ras plays a critical role in reovirus oncolysis in MB. Using an in vivo Daoy orthotopic animal model, we found that a single i.t. injection of reovirus dramatically prolonged survival compared with controls (160 versus 70 days, respectively; P = 0.0003). Repeating this experiment with GFP-labeled Daoy cells and multiple i.t. administrations of reovirus, we again found prolonged survival and a dramatic reduction in spinal and leptomeningeal metastases (66.7% in control injections versus 0.0% in the live virus group). These data suggest that this oncolytic virus may be a potentially effective novel therapy against human MB. Its ability to reduce metastases to the spinal cord could allow a reduction in the dose/field of total neuroaxis cerebral-spinal radiotherapy currently used to treat/prevent cerebral spinal fluid dissemination.
Subject(s)
Biological Therapy , Cerebellar Neoplasms/therapy , Mammalian orthoreovirus 3/physiology , Medulloblastoma/secondary , Meningeal Neoplasms/secondary , Spinal Cord Neoplasms/secondary , Animals , Drug Administration Schedule , Enzyme Activation , Eukaryotic Initiation Factor-2/antagonists & inhibitors , Female , Genes, Reporter , Genes, p53 , Green Fluorescent Proteins , Humans , Injections, Spinal , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Medulloblastoma/prevention & control , Medulloblastoma/therapy , Meningeal Neoplasms/prevention & control , Mice , Mice, Nude , Neoplasm Proteins/physiology , Proto-Oncogene Proteins p21(ras)/physiology , Signal Transduction , Spinal Cord Neoplasms/prevention & control , Transcription, Genetic , Tumor Cells, Cultured , Virus Replication , Xenograft Model Antitumor Assays , eIF-2 Kinase/antagonists & inhibitors , eIF-2 Kinase/physiologyABSTRACT
Leptomeningeal metastasis of low-grade gliomas in children has been documented in several series, both at the time of diagnosis and at relapse. The authors report a unique case of chiasmatic low-grade astrocytoma presenting with signs and symptoms related to the metastatic site rather than the primary site. In this respect, the possibility of appearance of symptoms and signs related to leptomeningeal dissemination preceding the signs and symptoms belonging to the primary site should be considered in this type of benign tumours.
Subject(s)
Astrocytoma/diagnosis , Hypothalamus/pathology , Optic Chiasm/pathology , Spinal Cord Neoplasms/diagnosis , Supratentorial Neoplasms/diagnosis , Astrocytoma/secondary , Astrocytoma/therapy , Child , Diagnosis, Differential , Humans , Magnetic Resonance Imaging , Male , Neoplasm Seeding , Sacrum , Spinal Cord Neoplasms/secondary , Spinal Cord Neoplasms/therapy , Supratentorial Neoplasms/pathology , Supratentorial Neoplasms/therapy , Treatment OutcomeABSTRACT
Following the basic principles of Sir Ludwig Guttmann in respect of the comprehensive care and management of spinal cord injured patients, the German SCI centers try to admit those freshly injured preferably on the first day of onset, providing spinal surgery and intensive care. In our series of recent comprehensive spinal paralysed patients admitted from Jan 1st 1993 to Dec 31st 1995 178 patients requested operative decompression and stabilization out of a total of 255 patients. 51.4% of the patients had been operated within the first 24 h, but 10.5% later than 2 weeks. A high incidence of reoperations (45.2%) must be noted in cases operated prior to the admittance to the SCI center due to failures of instrumentation or lack of anterior reconstruction. Nineteen patients with various spinal tumors underwent surgical treatment, and seven patients with spondylitis and severe neurological deficit. Only 64.4% of the 1st day admissions came in time for administration of high dose methylprednisolone according to the NASCIS II study. The additional pelvic and long bone fractures were operated on following the principles of the Swiss AO, thus achieving immediate mobilization as was also possible after surgical spine stabilization. Neurological recovery could only be found in those with incomplete lesions in more than 50% but also two with neurological deterioration had to be accepted in the paraplegic cohort. Eight who were tetraplegic and 14 with paraplegia died within the first 3 months, but nine with paraplegia had a tumor or spondylitis.
Subject(s)
Paralysis/surgery , Spinal Cord Injuries/surgery , Accidents, Traffic , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Inflammatory Agents/therapeutic use , Child , Child, Preschool , Female , Germany/epidemiology , Humans , Male , Methylprednisolone/therapeutic use , Middle Aged , Paralysis/drug therapy , Reoperation , Spinal Cord Diseases/complications , Spinal Cord Diseases/surgery , Spinal Cord Injuries/epidemiology , Spinal Cord Injuries/etiology , Spinal Cord Neoplasms/complications , Spinal Cord Neoplasms/secondary , Spinal Cord Neoplasms/surgery , Spondylitis/complications , Spondylitis/surgery , Treatment OutcomeABSTRACT
Epidural spinal cord stimulation was performed in a patient complaining of spasticity with intractable pain after operation of metastatic spinal tumor. The end of the electrode was positioned along a line extending down the 11th vertebral body. Following confirmation of satisfactory effects during 10 days of trial stimulation, the electrode was permanently implanted. Excellent pain relief (80%) and significant relaxation of spasticity resulted in a medication free period with improved daily activities. Although the treatment of this case resulted in clinical success, the problem concerning the payment of the transmitter remained. We hope that the health insurance system will extend its indications to cover medical fees for the transmitter.